These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30235216)

  • 41. Disease burden of human papillomavirus infection in the Netherlands, 1989-2014: the gap between females and males is diminishing.
    McDonald SA; Qendri V; Berkhof J; de Melker HE; Bogaards JA
    Cancer Causes Control; 2017 Mar; 28(3):203-214. PubMed ID: 28213874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiological Trends of Head and Neck Cancer in the United States: A SEER Population Study.
    Mourad M; Jetmore T; Jategaonkar AA; Moubayed S; Moshier E; Urken ML
    J Oral Maxillofac Surg; 2017 Dec; 75(12):2562-2572. PubMed ID: 28618252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
    Choi I; Lee D; Son KB; Bae S
    BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.
    Blomberg M; Nielsen A; Munk C; Kjaer SK
    Int J Cancer; 2011 Aug; 129(3):733-41. PubMed ID: 20878955
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
    Lam JO; Lim WY; Chow KY; D'Souza G
    PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health Care Costs of Anal Cancer in a Commercially Insured Population in the United States.
    Wu CF; Xu L; Fu S; Peng HL; Messick CA; Lairson DR
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1156-1164. PubMed ID: 30362917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human papillomavirus (HPV) prevalence and HPV type distribution in cervical, vulvar, and anal cancers in central and eastern Europe.
    Škamperle M; Kocjan BJ; Maver PJ; Seme K; Poljak M
    Acta Dermatovenerol Alp Pannonica Adriat; 2013; 22(1):1-5. PubMed ID: 23674179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From the monovalent to the nine-valent HPV vaccine.
    Pils S; Joura EA
    Clin Microbiol Infect; 2015 Sep; 21(9):827-33. PubMed ID: 25980355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genital warts and risk of cancer: a Danish study of nearly 50 000 patients with genital warts.
    Blomberg M; Friis S; Munk C; Bautz A; Kjaer SK
    J Infect Dis; 2012 May; 205(10):1544-53. PubMed ID: 22427679
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Annual cost of hospitalization, inpatient rehabilitation and sick leave of anal cancer in Germany.
    Heitland W; Schädlich PK; Chen X; Rémy V; Moro L
    J Med Econ; 2013; 16(3):364-71. PubMed ID: 23253056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of oral HPV infection among healthy individuals and head and neck cancer cases in the French West Indies.
    Auguste A; Gaëte S; Herrmann-Storck C; Michineau L; Joachim C; Deloumeaux J; Duflo S; Luce D
    Cancer Causes Control; 2017 Nov; 28(11):1333-1340. PubMed ID: 28948421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992-2009.
    Forte T; Niu J; Lockwood GA; Bryant HE
    Cancer Causes Control; 2012 Aug; 23(8):1343-8. PubMed ID: 22718355
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies.
    Tota JE; Chevarie-Davis M; Richardson LA; Devries M; Franco EL
    Prev Med; 2011 Oct; 53 Suppl 1():S12-21. PubMed ID: 21962466
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimation of the overall burden of cancers, precancerous lesions, and genital warts attributable to 9-valent HPV vaccine types in women and men in Europe.
    Hartwig S; St Guily JL; Dominiak-Felden G; Alemany L; de Sanjosé S
    Infect Agent Cancer; 2017; 12():19. PubMed ID: 28400857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer?
    Isaranuwatchai W; Graham DM; Siu LL; Hoch JS
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):763-5. PubMed ID: 25095728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases.
    Berman TA; Schiller JT
    Cancer; 2017 Jun; 123(12):2219-2229. PubMed ID: 28346680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Economic burden of anal cancer management in France.
    Abramowitz L; Rémy V; Vainchtock A
    Rev Epidemiol Sante Publique; 2010 Oct; 58(5):331-8. PubMed ID: 20869182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The first vaccine against cancer: the human papillomavirus vaccine].
    Bősze P
    Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human papillomavirus-associated cancers - United States, 2004-2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Apr; 61():258-61. PubMed ID: 22513527
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The indirect costs of human papillomavirus-related cancer in Central and Eastern Europe: years of life lost and productivity costs.
    Sabale U; Karamousouli E; Popovic L; Krasznai ZT; Harrop D; Meiwald A; Hughes R; Weston G; Bencina G
    J Med Econ; 2024 Apr; 27(sup2):1-8. PubMed ID: 38638098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.